Seven pharma giants join Parkinsons consortium savita thakur thakur25 Feb 2016 12:45 PM ISTAstraZeneca, Pfizer and Eli Lilly are among seven major pharmaceutical companies linking into a “ground-breaking” consortium striving to streamline...
AstraZeneca wins FDA breakthrough status for durvalumab savita thakur thakur18 Feb 2016 9:16 AM ISTLONDON: The U.S. Food and Drug Administration has granted breakthrough therapy designation to AstraZeneca's biggest new drug hope durvalumab as a...
GSK, Astra, J&J link with universities in new drug research fund savita thakur thakur26 Jan 2016 9:29 AM ISTLondon : GlaxoSmithKline, AstraZeneca and Johnson & Johnson have joined with three leading British universities to create a new 40 million pounds...
Sanofi deepens cancer drive with two deals worth $1.2 billion, Innate jumps savita thakur thakur12 Jan 2016 9:24 AM ISTParis: Sanofi boosted its presence in cancer research by signing two deals with biotech companies worth up to $1.2 billion, as the French drugmaker...
FDA approves Zurampic to treat high blood uric acid levels associated with gout savita thakur thakur23 Dec 2015 10:26 AM ISTThe U.S. Food and Drug Administration approved Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperuricemia) associated with...
Europe recommends lung cancer drugs from AstraZeneca, Lilly savita thakur thakur19 Dec 2015 11:41 AM ISTThe European Medicines Agency said its experts had recommended marketing approval for lung cancer drugs developed by AstraZeneca and Eli Lilly and...
AstraZeneca in talks to buy cancer drugmaker Acerta for $5 billion: WSJ savita thakur thakur12 Dec 2015 11:14 AM ISTBritish drugmaker AstraZeneca Plc is in advanced talks to buy privately held cancer drug developer Acerta Pharma BV for more than $5 billion (3.3...
Sanofi, AstraZeneca in major drug-sharing deal savita thakur thakur23 Nov 2015 5:10 PM ISTFrench pharmaceutical company Sanofi and Britain's AstraZeneca said they have agreed to share freely 210,000 proprietary chemical compounds as they...
FDA approves new pill for non-small cell lung cancer Meghna A Singhania15 Nov 2015 3:58 PM ISTU.S. Food and Drug Administration granted accelerated approval for an oral medication to treat patients with advanced non-small cell lung cancer...
AstraZeneca buys ZS Pharma for $2.7 billion, pips Actelion Pooja Bhatia Bhatia7 Nov 2015 9:00 AM ISTLondon: Britain's AstraZeneca has said that it had agreed to buy U.S biotech company ZS Pharma for $2.7 billion, pipping Swiss firm Actelion to...
AstraZeneca halts clinical trials of its drugs to treat lung cancer Pooja Bhatia Bhatia10 Oct 2015 12:45 PM ISTAfter reports of developing lung cancers in some patients, AstraZeneca has temporarily halted two clinical trials combining experimental drugs to...
